Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra M Adams

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Annals of Surgical Oncology|June 17, 2023
Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic AdenocarcinomaHolly V Spitzer, Phillip M Kemp Bohan, Elizabeth L Carpenter, et al.
Journal of Surgical Oncology|May 20, 2025
A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System)Spencer G Van Decar, Elizabeth L Barbera, Alexandra M Adams, et al.
Oncotargets and Therapy|June 9, 2021
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal AdenocarcinomaPatrick M McCarthy, Matthew J Rendo, Matthew D Uy, et al.
Annals of Surgical Oncology|May 18, 2022
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves SurvivalAnne E O'Shea, Phillip M Kemp Bohan, Elizabeth L Carpenter, et al.
Journal of Surgical Oncology|May 27, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapyElizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, et al.
Clinical Immunology (Orlando, Fla.)|August 16, 2022
Immunologic and dose dependent effects of rapamycin and its evolving role in chemopreventionAnne E O'Shea, Franklin A Valdera, Daniel Ensley, et al.
Frontiers in Immunology|March 24, 2023
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trialsPatrick M McCarthy, Franklin A Valdera, Todd R Smolinsky, et al.
Annals of Surgical Oncology|February 28, 2021
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary AnalysisTimothy J Vreeland, Guy T Clifton, Diane F Hale, et al.
Annals of Surgical Oncology|June 14, 2026
Longitudinal Symptom Recovery After Pancreatectomy: A Prospective Patient-Reported Outcomes Study using MDASIKoichi Tomita, Alexandra M Adams, Maho Takayama, et al.
Annals of Surgical Oncology|June 27, 2026
ASO Visual Abstract: Longitudinal Symptom Recovery After Pancreatectomy-A Prospective Patient-Reported Outcomes Study using MDASIKoichi Tomita, Alexandra M Adams, Maho Takayama, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|June 17, 2023
Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic AdenocarcinomaHolly V Spitzer, Phillip M Kemp Bohan, Elizabeth L Carpenter, et al.
Journal of Surgical Oncology|May 20, 2025
A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System)Spencer G Van Decar, Elizabeth L Barbera, Alexandra M Adams, et al.
Oncotargets and Therapy|June 9, 2021
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal AdenocarcinomaPatrick M McCarthy, Matthew J Rendo, Matthew D Uy, et al.
Annals of Surgical Oncology|May 18, 2022
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves SurvivalAnne E O'Shea, Phillip M Kemp Bohan, Elizabeth L Carpenter, et al.
Journal of Surgical Oncology|May 27, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapyElizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, et al.
Clinical Immunology (Orlando, Fla.)|August 16, 2022
Immunologic and dose dependent effects of rapamycin and its evolving role in chemopreventionAnne E O'Shea, Franklin A Valdera, Daniel Ensley, et al.
Frontiers in Immunology|March 24, 2023
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trialsPatrick M McCarthy, Franklin A Valdera, Todd R Smolinsky, et al.
Annals of Surgical Oncology|February 28, 2021
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary AnalysisTimothy J Vreeland, Guy T Clifton, Diane F Hale, et al.
Annals of Surgical Oncology|June 14, 2026
Longitudinal Symptom Recovery After Pancreatectomy: A Prospective Patient-Reported Outcomes Study using MDASIKoichi Tomita, Alexandra M Adams, Maho Takayama, et al.
Annals of Surgical Oncology|June 27, 2026
ASO Visual Abstract: Longitudinal Symptom Recovery After Pancreatectomy-A Prospective Patient-Reported Outcomes Study using MDASIKoichi Tomita, Alexandra M Adams, Maho Takayama, et al.
Pageof 4